Witte J, Schlotmann U, Simon D, Dotzenrath C, Ohmann C, Goretzki P E
Klinik für Allgemeine- und Unfallchirurgie, Heinrich-Heine-Universität Düsseldorf.
Zentralbl Chir. 1997;122(4):259-65.
Surgical therapy of differentiated thyroid cancer (DTC) includes thyroidectomy plus central lymph node dissection and postoperative radioiodine therapy. In cases of lymph node metastasis, T3/T4 tumors and C-cell-carcinoma (after thyroidectomy) uni- or bilateral modified radical lymph node dissection of the neck (neck dissection) and of the mediastinum is recommended. The importance of lymph node metastasis for prognosis of survival in papillary, follicular and C-cell-carcinoma is discussed controversial, however. Even the kind of surgical radicality is questioned. Thus a metaanalysis of 35 studies in 29 independent publications from a pool of 2186 studies was performed. Univariate analysis demonstrates lymph node metastasis as a negative prognostic factor in papillary carcinoma with a 3.25/2.97, in follicular carcinoma with a 7.62/4.0 and in C-cell-carcinoma with a 3.33/3.37 higher probability of mortality 5 and 10 years after operation. Modification of the present surgical therapy can therefore only be accepted after univariate and multivariate analysis of all prognostic factors (age, sex, cell type, tumor extent, lymph node- and distant metastasis) and after it has proven superiority to the present strategy in prospective randomised trials.
分化型甲状腺癌(DTC)的外科治疗包括甲状腺切除术加中央淋巴结清扫术以及术后放射性碘治疗。对于出现淋巴结转移、T3/T4期肿瘤以及(甲状腺切除术后的)C细胞癌患者,建议进行颈部(颈部清扫术)和纵隔的单侧或双侧改良根治性淋巴结清扫术。然而,淋巴结转移对乳头状癌、滤泡状癌和C细胞癌生存预后的重要性存在争议。甚至手术根治程度也受到质疑。因此,我们对来自2186项研究的29篇独立出版物中的35项研究进行了荟萃分析。单因素分析表明,淋巴结转移是乳头状癌、滤泡状癌和C细胞癌的负面预后因素,术后5年和10年的死亡概率分别高出3.25/2.97、7.62/4.0和3.33/3.37。因此,只有在对所有预后因素(年龄、性别、细胞类型、肿瘤范围、淋巴结和远处转移)进行单因素和多因素分析,并在前瞻性随机试验中证明其优于当前策略之后,才能接受对当前手术治疗的改进。